PMC:3586680 / 155-323 JSONTXT

Annnotations TAB JSON ListView MergeView

    test3

    {"project":"test3","denotations":[{"id":"T65","span":{"begin":146,"end":150},"obj":"Protein"},{"id":"T64","span":{"begin":139,"end":142},"obj":"Protein"},{"id":"T63","span":{"begin":133,"end":137},"obj":"Protein"},{"id":"T62","span":{"begin":97,"end":132},"obj":"Protein"},{"id":"T47","span":{"begin":146,"end":150},"obj":"Protein"},{"id":"T46","span":{"begin":139,"end":142},"obj":"Protein"},{"id":"T45","span":{"begin":133,"end":137},"obj":"Protein"},{"id":"T44","span":{"begin":97,"end":132},"obj":"Protein"}],"relations":[{"id":"R5","pred":"themeOf","subj":"T63","obj":"T64"},{"id":"R6","pred":"equivalentTo","subj":"T64","obj":"T62"}],"text":") and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptoti"}

    testone

    {"project":"testone","denotations":[{"id":"T25","span":{"begin":146,"end":150},"obj":"Protein"},{"id":"T24","span":{"begin":139,"end":142},"obj":"Protein"},{"id":"T23","span":{"begin":133,"end":137},"obj":"Protein"},{"id":"T22","span":{"begin":97,"end":132},"obj":"Protein"}],"text":") and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptoti"}

    bionlp-st-ge-2016-test-tees

    {"project":"bionlp-st-ge-2016-test-tees","denotations":[{"id":"T479","span":{"begin":146,"end":150},"obj":"Protein"},{"id":"T478","span":{"begin":139,"end":142},"obj":"Protein"},{"id":"T477","span":{"begin":118,"end":137},"obj":"Protein"}],"text":") and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptoti"}

    bionlp-st-ge-2016-spacy-parsed

    {"project":"bionlp-st-ge-2016-spacy-parsed","denotations":[{"id":"T603","span":{"begin":155,"end":156},"obj":"DT"},{"id":"T602","span":{"begin":152,"end":154},"obj":"VBZ"},{"id":"T601","span":{"begin":150,"end":151},"obj":"-RRB-"},{"id":"T600","span":{"begin":146,"end":150},"obj":"CD"},{"id":"T599","span":{"begin":143,"end":145},"obj":"CC"},{"id":"T598","span":{"begin":139,"end":142},"obj":"IN"},{"id":"T597","span":{"begin":138,"end":139},"obj":"-LRB-"},{"id":"T596","span":{"begin":133,"end":137},"obj":"NNP"},{"id":"T595","span":{"begin":118,"end":132},"obj":"NN"},{"id":"T594","span":{"begin":100,"end":117},"obj":"JJ"},{"id":"T593","span":{"begin":97,"end":99},"obj":"NNP"},{"id":"T592","span":{"begin":95,"end":96},"obj":"."},{"id":"T591","span":{"begin":90,"end":95},"obj":"NNS"},{"id":"T590","span":{"begin":78,"end":89},"obj":"JJ"},{"id":"T589","span":{"begin":74,"end":77},"obj":"CC"},{"id":"T588","span":{"begin":72,"end":73},"obj":"-RRB-"},{"id":"T587","span":{"begin":69,"end":72},"obj":"NNP"},{"id":"T586","span":{"begin":68,"end":69},"obj":"-LRB-"},{"id":"T585","span":{"begin":55,"end":67},"obj":"VB"},{"id":"T584","span":{"begin":52,"end":54},"obj":"TO"},{"id":"T583","span":{"begin":41,"end":51},"obj":"NN"},{"id":"T582","span":{"begin":38,"end":40},"obj":"TO"},{"id":"T581","span":{"begin":36,"end":37},"obj":","},{"id":"T580","span":{"begin":32,"end":36},"obj":"NN"},{"id":"T579","span":{"begin":29,"end":31},"obj":"IN"},{"id":"T578","span":{"begin":27,"end":28},"obj":","},{"id":"T577","span":{"begin":17,"end":27},"obj":"VB"},{"id":"T576","span":{"begin":14,"end":16},"obj":"TO"},{"id":"T575","span":{"begin":6,"end":13},"obj":"VBZ"},{"id":"T574","span":{"begin":2,"end":5},"obj":"CC"},{"id":"T573","span":{"begin":0,"end":1},"obj":"-RRB-"}],"relations":[{"id":"R289","pred":"aux","subj":"T576","obj":"T577"},{"id":"R290","pred":"xcomp","subj":"T577","obj":"T575"},{"id":"R291","pred":"punct","subj":"T578","obj":"T577"},{"id":"R292","pred":"prep","subj":"T579","obj":"T575"},{"id":"R293","pred":"pobj","subj":"T580","obj":"T579"},{"id":"R294","pred":"punct","subj":"T581","obj":"T575"},{"id":"R295","pred":"aux","subj":"T582","obj":"T583"},{"id":"R297","pred":"aux","subj":"T584","obj":"T585"},{"id":"R298","pred":"advcl","subj":"T585","obj":"T583"},{"id":"R299","pred":"punct","subj":"T586","obj":"T587"},{"id":"R300","pred":"appos","subj":"T587","obj":"T585"},{"id":"R301","pred":"punct","subj":"T588","obj":"T587"},{"id":"R302","pred":"cc","subj":"T589","obj":"T585"},{"id":"R303","pred":"amod","subj":"T590","obj":"T591"},{"id":"R304","pred":"conj","subj":"T591","obj":"T585"},{"id":"R306","pred":"compound","subj":"T593","obj":"T596"},{"id":"R307","pred":"compound","subj":"T594","obj":"T596"},{"id":"R308","pred":"compound","subj":"T595","obj":"T596"},{"id":"R309","pred":"nsubj","subj":"T596","obj":"T602"},{"id":"R310","pred":"punct","subj":"T597","obj":"T598"},{"id":"R311","pred":"prep","subj":"T598","obj":"T596"},{"id":"R312","pred":"cc","subj":"T599","obj":"T598"},{"id":"R313","pred":"conj","subj":"T600","obj":"T598"},{"id":"R314","pred":"punct","subj":"T601","obj":"T598"},{"id":"R315","pred":"ROOT","subj":"T602","obj":"T602"}],"text":") and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptoti"}

    bionlp-st-ge-2016-test-ihmc

    {"project":"bionlp-st-ge-2016-test-ihmc","denotations":[{"id":"T537","span":{"begin":97,"end":132},"obj":"Protein"},{"id":"T535","span":{"begin":55,"end":73},"obj":"Entity"},{"id":"T534","span":{"begin":146,"end":150},"obj":"Protein"},{"id":"T532","span":{"begin":97,"end":137},"obj":"Protein"},{"id":"T526","span":{"begin":78,"end":95},"obj":"Entity"},{"id":"T523","span":{"begin":69,"end":72},"obj":"Entity"}],"text":") and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptoti"}

    DLUT931

    {"project":"DLUT931","denotations":[{"id":"T403","span":{"begin":146,"end":150},"obj":"Protein"},{"id":"T402","span":{"begin":139,"end":142},"obj":"Protein"},{"id":"T401","span":{"begin":133,"end":137},"obj":"Protein"},{"id":"T400","span":{"begin":97,"end":132},"obj":"Protein"}],"text":") and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptoti"}

    BioNLP16_Messiy

    {"project":"BioNLP16_Messiy","denotations":[{"id":"T453","span":{"begin":146,"end":150},"obj":"Protein"},{"id":"T452","span":{"begin":139,"end":142},"obj":"Protein"},{"id":"T451","span":{"begin":133,"end":137},"obj":"Protein"},{"id":"T450","span":{"begin":97,"end":132},"obj":"Protein"}],"text":") and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptoti"}

    BioNLP16_DUT

    {"project":"BioNLP16_DUT","denotations":[{"id":"T361","span":{"begin":146,"end":150},"obj":"Protein"},{"id":"T360","span":{"begin":139,"end":142},"obj":"Protein"},{"id":"T359","span":{"begin":133,"end":137},"obj":"Protein"},{"id":"T358","span":{"begin":97,"end":132},"obj":"Protein"}],"text":") and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptoti"}

    bionlp-st-ge-2016-uniprot

    {"project":"bionlp-st-ge-2016-uniprot","denotations":[{"id":"T389","span":{"begin":146,"end":150},"obj":"http://www.uniprot.org/uniprot/Q9NZC7"},{"id":"T388","span":{"begin":139,"end":142},"obj":"http://www.uniprot.org/uniprot/Q9NZC7"},{"id":"T382","span":{"begin":133,"end":137},"obj":"http://www.uniprot.org/uniprot/Q9NZC7"}],"namespaces":[{"prefix":"_base","uri":"http://www.uniprot.org/uniprot/"}],"text":") and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptoti"}

    bionlp-st-ge-2016-test-proteins

    {"project":"bionlp-st-ge-2016-test-proteins","denotations":[{"id":"T121","span":{"begin":97,"end":132},"obj":"Protein"},{"id":"T122","span":{"begin":133,"end":137},"obj":"Protein"},{"id":"T123","span":{"begin":139,"end":142},"obj":"Protein"},{"id":"T124","span":{"begin":146,"end":150},"obj":"Protein"}],"namespaces":[{"prefix":"_base","uri":"http://bionlp.dbcls.jp/ontology/ge.owl#"}],"text":") and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptoti"}

    pmc-enju-pas

    {"project":"pmc-enju-pas","denotations":[{"id":"T216","span":{"begin":155,"end":156},"obj":"DT"},{"id":"T215","span":{"begin":152,"end":154},"obj":"VB"},{"id":"T214","span":{"begin":150,"end":151},"obj":"-RRB-"},{"id":"T213","span":{"begin":146,"end":150},"obj":"NN"},{"id":"T212","span":{"begin":143,"end":145},"obj":"CC"},{"id":"T211","span":{"begin":139,"end":142},"obj":"NN"},{"id":"T210","span":{"begin":138,"end":139},"obj":"-LRB-"},{"id":"T209","span":{"begin":133,"end":137},"obj":"NN"},{"id":"T208","span":{"begin":118,"end":132},"obj":"NN"},{"id":"T207","span":{"begin":100,"end":117},"obj":"JJ"},{"id":"T206","span":{"begin":97,"end":99},"obj":"JJ"},{"id":"T205","span":{"begin":90,"end":95},"obj":"NN"},{"id":"T204","span":{"begin":78,"end":89},"obj":"JJ"},{"id":"T203","span":{"begin":74,"end":77},"obj":"CC"},{"id":"T202","span":{"begin":72,"end":73},"obj":"-RRB-"},{"id":"T201","span":{"begin":69,"end":72},"obj":"NN"},{"id":"T200","span":{"begin":68,"end":69},"obj":"-LRB-"},{"id":"T199","span":{"begin":55,"end":67},"obj":"NN"},{"id":"T198","span":{"begin":52,"end":54},"obj":"TO"},{"id":"T197","span":{"begin":41,"end":51},"obj":"NN"},{"id":"T196","span":{"begin":38,"end":40},"obj":"TO"},{"id":"T195","span":{"begin":36,"end":37},"obj":"-COMMA-"},{"id":"T194","span":{"begin":32,"end":36},"obj":"NN"},{"id":"T193","span":{"begin":29,"end":31},"obj":"IN"},{"id":"T192","span":{"begin":27,"end":28},"obj":"-COMMA-"},{"id":"T191","span":{"begin":17,"end":27},"obj":"VB"},{"id":"T190","span":{"begin":14,"end":16},"obj":"TO"},{"id":"T189","span":{"begin":6,"end":13},"obj":"VB"},{"id":"T188","span":{"begin":2,"end":5},"obj":"CC"},{"id":"T187","span":{"begin":0,"end":1},"obj":"-RRB-"}],"relations":[{"id":"R52","pred":"arg2Of","subj":"T189","obj":"T188"},{"id":"R53","pred":"arg2Of","subj":"T191","obj":"T189"},{"id":"R54","pred":"arg1Of","subj":"T191","obj":"T190"},{"id":"R55","pred":"arg1Of","subj":"T191","obj":"T192"},{"id":"R56","pred":"arg1Of","subj":"T191","obj":"T193"},{"id":"R57","pred":"arg1Of","subj":"T191","obj":"T195"},{"id":"R58","pred":"arg1Of","subj":"T191","obj":"T196"},{"id":"R59","pred":"arg2Of","subj":"T194","obj":"T193"},{"id":"R60","pred":"arg1Of","subj":"T197","obj":"T198"},{"id":"R61","pred":"arg1Of","subj":"T197","obj":"T203"},{"id":"R62","pred":"arg2Of","subj":"T199","obj":"T198"},{"id":"R63","pred":"arg1Of","subj":"T199","obj":"T200"},{"id":"R64","pred":"arg2Of","subj":"T201","obj":"T200"},{"id":"R65","pred":"arg3Of","subj":"T202","obj":"T200"},{"id":"R66","pred":"arg2Of","subj":"T203","obj":"T196"},{"id":"R67","pred":"arg2Of","subj":"T205","obj":"T203"},{"id":"R68","pred":"arg1Of","subj":"T205","obj":"T204"},{"id":"R69","pred":"arg1Of","subj":"T209","obj":"T206"},{"id":"R70","pred":"arg1Of","subj":"T209","obj":"T207"},{"id":"R71","pred":"arg1Of","subj":"T209","obj":"T208"},{"id":"R72","pred":"arg1Of","subj":"T209","obj":"T210"},{"id":"R73","pred":"arg1Of","subj":"T209","obj":"T215"},{"id":"R76","pred":"arg1Of","subj":"T211","obj":"T212"},{"id":"R77","pred":"arg2Of","subj":"T212","obj":"T210"},{"id":"R78","pred":"arg2Of","subj":"T213","obj":"T212"},{"id":"R79","pred":"arg3Of","subj":"T214","obj":"T210"}],"namespaces":[{"prefix":"_base","uri":"http://kmcs.nii.ac.jp/enju/"}],"text":") and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptoti"}

    simple1

    {"project":"simple1","denotations":[{"id":"T154","span":{"begin":146,"end":150},"obj":"Protein"},{"id":"T153","span":{"begin":139,"end":142},"obj":"Protein"},{"id":"T152","span":{"begin":133,"end":137},"obj":"Protein"},{"id":"T151","span":{"begin":97,"end":132},"obj":"Protein"}],"text":") and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptoti"}